U.S.-China Economic and Security Review Commission Hearing on China and Global Health
On July 31, 2019, the U.S.-China Economic and Security Review Commission held a hearing on the role China plays in global health industries and how that impacts the United States. Health experts discussed the impact China’s pharmaceutical industry has had on the United States, specifically regarding drug safety, cost, availability, and research.
NBR President Roy Kamphausen participated in the hearing in his capacity as a commissioner. Watch video clips of Kamphausen’s remarks.
Full video from the hearing